Clinical Trial Update: Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating lenalidomide plus decitabine in high-grade myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)
• Revlimid (lenalidomide)

Snippet

Sponsor: Duke University | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED